# DoD Peer Reviewed Alzheimer’s Research Program, Translational Research Award

Source: https://welltoldgrants.com/grants/w81xwh-22-prarp-tra-dod-peer-reviewed-alzheimers-research-program-translational/  
Official notice: https://www.grants.gov/search-results-detail/339680

> Defense Health Agency Contracting Activity - DHACA offered grants to any type of organization. It expected to make about 2 awards worth $2.4 million in total. Applications closed on July 25, 2022.

| Field | Value |
|---|---|
| Opportunity number | W81XWH-22-PRARP-TRA |
| Agency | Defense Health Agency Contracting Activity - DHACA |
| Status | Forecast |
| Deadline | July 25, 2022 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | 2 |
| Total funding | $2.4 million |
| Cost sharing | not required |
| Assistance Listings | 12.420 |

## Who can apply

- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

## What the grant funds

The intent of the FY22 PRARP TRA is to support translational research that will accelerate the movement of promising products and knowledge in AD/ADRD research into clinical applications, including healthcare products and interventions, technologies, behavioral modalities, social modalities, and/or clinical practice guidelines. This mechanism supports both preclinical-to-clinical translational research (e.g., studies of interventions and medical devices in preclinical systems) and clinical research-to-clinical care translation (e.g., comparative effectiveness, implementation science, healthcare services research). Observations that support a research idea may be derived from a laboratory discovery, population-based studies, or a clinician’s first-hand knowledge of patients and anecdotal data. Inclusion of preliminary data is required. Use of animal models, if applicable, must be fully justified for relevance to human health. Clinical research applications are required to include a community collaboration research element. Important aspects of this award mechanism include: Translational Potential: The PRARP does not view translational research as a one-way continuum from bench to bedside. The research plan is encouraged to involve a reciprocal flow of ideas and information between basic and clinical science or clinical and implementation science as appropriate. The application should detail steps to move the research along the research and development continuum. Relevance to Military Health: Projects must have relevance to military Service Members, Veterans, and/or their family members and care partners. Applicants are encouraged to integrate and/or align their research projects with Department of Defense (DOD) and/or Department of Veterans Affairs (VA) research laboratories and programs. Collaborations between researchers, at military or Veterans institutions and non-military institutions, are strongly encouraged. A list of websites that may be useful in identifying additional information about ongoing DOD and VA areas of research interest or potential opportunities for collaboration can be found in Appendix 2.

## Questions people ask

### Is W81XWH-22-PRARP-TRA still open?

No. It closed on July 25, 2022. A newer notice is open: HT942526BCRPCREA2, closes November 18, 2026 (11 days left).

### Who can apply for DoD Peer Reviewed Alzheimer’s Research Program, Translational Research Award?

Defense Health Agency Contracting Activity - DHACA accepted applications from any type of organization.

### What is the deadline for DoD Peer Reviewed Alzheimer’s Research Program, Translational Research Award?

Closed July 25, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

About $2.4 million in total across about 2 awards.

### Who has won Military Medical Research and Development grants before?

The largest recipients over five fiscal years were The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., The Univeristy of Texas M.D. Anderson Cancer Center, The Johns Hopkins University. The program made 5,470 awards worth $6.9 billion in that time.